Education
| School — Major — Degree | Duration |
|---|---|
|
國立成功大學 — 臨床藥學與藥物科技研究所(畢) — 博士 Doctorate, Institute of Clinical Pharmacy and Pharmaceutical Sciences, National Cheng Kung University |
2008/09 — 2012/12 |
|
國立交通大學 — 生物科技研究所(畢) — 碩士 Master, Department of Biological Science and Technology, National Chiao Tung University |
2003/07 — 2005/06 |
|
國立交通大學 — 生物科技系(畢) — 學士 Bachelor, Department of Biological Science and Technology, National Chiao Tung University |
1999/09 — 2003/06 |
Intramural Experience
| Office/Department/Institute | Position | Duration |
|---|---|---|
| 學士後醫學系 School of Post-Baccalaureate Medicine | Assistant Professor | 2023/08/01 — |
Extramural Experience
| DEPNO | Position- Office/Department/Institute | Duration |
|---|---|---|
| 助理教授 | 1120201 — 1120731 |
Discipline
Research & Technology Platform Open to the Outside
Interested Area(s)for Interdisciplinary Research
Area(s) of Expertise & Research
研究專長：細胞生物學、生理學、分子醫學、轉譯醫學、再生醫學、標靶治療、癌症抗藥性， 研究領域： 1. 癌症(探討核內KIT蛋白調控之基因表現在胃腸道基質瘤中癌化之角色與治療標的; 探討現有標靶藥物對具Temozolomide抗藥性之多形性膠質母細胞瘤治療之可行性與作用機轉) 2. 精神疾患(探討雙極性疾患中生物標記蛋白對神經細胞的分子機轉)
Publication
| NO | Publication |
|---|---|
| 1 | Ethanol extract of Vanilla planifolia stems reduces PAK6 expression and induces cell death in glioblastoma cells. Ethanol extract of Vanilla planifolia stems reduces PAK6 expression and induces cell death in glioblastoma cells. |
| 2 | A Selective Histone Deacetylase Inhibitor Induces Autophagy and Cell Death via SCNN1A Downregulation in Glioblastoma Cells. A Selective Histone Deacetylase Inhibitor Induces Autophagy and Cell Death via SCNN1A Downregulation in Glioblastoma Cells. |
| 3 | A Longitudinal Study of the Association between the Polymorphism and Treatment Response in Patients with Bipolar Disorder. A Longitudinal Study of the Association between the Polymorphism and Treatment Response in Patients with Bipolar Disorder. |
| 4 | Intraovarian Injection of Recombinant Human Follicle-Stimulating Hormone for Luteal-Phase Ovarian Stimulation during Oocyte Retrieval Is Effective in Women with Impending Ovarian Failure and Diminished Ovarian Reserve. Intraovarian Injection of Recombinant Human Follicle-Stimulating Hormone for Luteal-Phase Ovarian Stimulation during Oocyte Retrieval Is Effective in Women with Impending Ovarian Failure and Diminished Ovarian Reserve. |
| 5 | Ovarian Follicular Growth through Intermittent Vaginal Gonadotropin Administration in Diminished Ovarian Reserve Women. Ovarian Follicular Growth through Intermittent Vaginal Gonadotropin Administration in Diminished Ovarian Reserve Women. |
| 6 | A heat shock protein 90 inhibitor reduces oncoprotein expression and induces cell death in heterogeneous glioblastoma cells with EGFR, PDGFRA, CDK4, and NF1 aberrations. A heat shock protein 90 inhibitor reduces oncoprotein expression and induces cell death in heterogeneous glioblastoma cells with EGFR, PDGFRA, CDK4, and NF1 aberrations. |
| 7 | Ovarian Folliculogenesis and Uterine Endometrial Receptivity after Intermittent Vaginal Injection of Recombinant Human Follicle-Stimulating Hormone in Infertile Women Receiving In Vitro Fertilization and in Immature Female Rats. Ovarian Folliculogenesis and Uterine Endometrial Receptivity after Intermittent Vaginal Injection of Recombinant Human Follicle-Stimulating Hormone in Infertile Women Receiving In Vitro Fertilization and in Immature Female Rats. |
| 8 | Nanostructured Lipid Carrier Gel Formulation of Recombinant Human Thrombomodulin Improve Diabetic Wound Healing by Topical Administration. Nanostructured Lipid Carrier Gel Formulation of Recombinant Human Thrombomodulin Improve Diabetic Wound Healing by Topical Administration. |
| 9 | Changes in striatal dopamine transporters in bipolar disorder and valproate treatment. Changes in striatal dopamine transporters in bipolar disorder and valproate treatment. |
Project
| NO |
YEAR — Source — No — Type
Project Name
|
Duration |
|---|---|---|
| 1 |
113 — N 國科會(原科技部) — NSTC113-2320-B-037-025 — 1 個人型
探討瓜氨酸化轉譯後修飾之蛋白質在神經膠質母細胞瘤生成和惡化的角色( )
|
2024/08/01 ~ 2025/07/31 |
| 2 |
112 — Q 新聘教師計畫(校內) — KMU-Q113010 —
探討PAK6在異質性神經膠質母細胞瘤中的致癌角色與可行性治療( )
|
2024/01/01 ~ 2024/12/31 |
| 3 |
112 — X 高奇合作計畫 — 113CM-KMU-10 —
探討尿液miRNA在台灣尿路上皮癌病人預後與治療的角色( )
|
2024/08/01 ~ 2025/07/31 |